Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $5.34B | $4.87B | +9.62% |
Cost of Revenue | $714.5M | $575.5M | +24.15% |
Operating Income | $-2.38B | $1.81B | -231.56% |
Net Income | $-2.49B | $1.62B | -254.38% |
EPS (Basic) | $-9.66 | $6.27 | -254.07% |
EPS (Diluted) | $-9.66 | $6.21 | -255.56% |
SG&A Expense | $714.9M | $503.7M | +41.93% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $20.13B | $20.35B | -1.07% |
Current Assets | $8.94B | $13.87B | -35.55% |
Total Liabilities | $5.36B | $4.88B | +9.81% |
Current Liabilities | $3.55B | $3.35B | +5.82% |
Stockholders' Equity | $14.77B | $15.47B | -4.50% |
Cash & Equivalents | $4.58B | $10.15B | -54.88% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-2.45B | $2.03B | -220.29% |
Investing Cash Flow | $-2.6B | $-2.14B | -21.64% |
Financing Cash Flow | $-716.1M | $-277.4M | -158.15% |
Share Buybacks | $451.5M | $161.1M | +180.26% |
D&A | $107.5M | $80.2M | +34.04% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -44.5% | 37.1% | -81.60% |
Net Margin | -46.7% | — | — |
ROE | -16.9% | — | — |
ROA | -12.4% | — | — |
Current Ratio | $2.521 | — | — |
Debt to Equity | $0.363 | — | — |
Other companies in Biotechnology